An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Nature Genetics2014Vol. 46(4), pp. 364–370
Citations Over TimeTop 1% of 2014 papers
Birgit Knoechel, Justine E. Roderick, Kaylyn E. Williamson, Jiang Zhu, Jens G. Lohr, Matthew J. Cotton, Shawn Gillespie, Daniel E. Fernandez, Manching Ku, Hongfang Wang, Federica Piccioni, Serena J. Silver, Mohit Jain, Daniel S. Pearson, Michael Kluk, Christopher J. Ott, Leonard D. Shultz, Michael A. Brehm, Dale L. Greiner, Alejandro Gutiérrez, Kimberly Stegmaier, Andrew L. Kung, David E. Root, James E. Bradner, Jon C. Aster, Michelle A. Kelliher, B Bernstein
Related Papers
- → Progress and promises of epigenetic drugs and epigenetic diets in cancer prevention and therapy: A clinical update(2020)82 cited
- → Epigenetic Therapy for Breast Cancer(2011)46 cited
- → Epigenetic therapy of hematological malignancies: where are we now?(2012)25 cited
- → Molecular Targets for Epigenetic Therapy of Cancer(2009)16 cited
- → Epigenetic Therapy should be in the Tool Box for Recurrent Ovarian Cancer(2020)